These bioinformatic analytic findings indicate that pseudogene DUXAP8 and DUXAP9 may fuel onset and development of renal cell carcinoma by targeting COL1A1 and COL1A2 through competitively binding miR-29c-3p. Here, DUXAP8 is linked to hereditary clear cell renal cell carcinoma.